Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

Can the PEMT rs7946 CT variant reduce hepatic phosphatidylcholine resilience and affect thyroid hormone activation?

The PEMT rs7946 CT variant can reduce hepatic phosphatidylcholine resilience, and hepatic thyroid hormone activation depends on healthy liver metabolism and lipid handling.

SupportedJuly 26, 202615 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

The PEMT rs7946 CT variant can reduce hepatic phosphatidylcholine resilience, and hepatic thyroid hormone activation depends on healthy liver metabolism and lipid handling.

laying out figure…
0 of 1 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

This claim says the PEMT rs7946 CT variant weakens phosphatidylcholine synthesis in the liver, which can make lipid export less resilient. The mechanism framing links that reduced lipid handling to greater triglyceride buildup and to changes in the hepatic pathways that activate thyroid hormone locally. It presents liver phosphatidylcholine status and thyroid hormone activation as part of the same integrated metabolic process.

Verified conclusion

The liver's capacity to process lipids and activate thyroid hormones is a highly integrated system relying on genetic resilience and precise enzymatic pathways.

Genetic and metabolic resilience

  • The PEMT rs7946 CT variant reduces the enzymatic activity of phosphatidylethanolamine N-methyltransferase by approximately 30%, which directly impairs de novo hepatic phosphatidylcholine (PC) synthesis.
  • PC is a critical structural component required for very-low-density lipoprotein (VLDL) assembly and secretion. Compromised PC synthesis impairs lipid export, increasing susceptibility to non-alcoholic fatty liver disease (NAFLD) by up to threefold during dietary choline deficiency.

Hepatic thyroid hormone activation

  • Local activation of thyroxine (T4) to active triiodothyronine (T3) is mediated by hepatic type 1 deiodinase (DIO1), an enzyme highly sensitive to liver lipid handling.
  • In early-stage hepatic steatosis, DIO1 is compensatorily upregulated to increase local T3 levels and stimulate fat oxidation.
  • In advanced metabolic dysfunction-associated steatohepatitis (NASH), this system fails; DIO1 is downregulated and the inactivating deiodinase type 3 (DIO3) is upregulated, inducing localized intrahepatic hypothyroidism that accelerates triglyceride accumulation.

Mechanistic interactions

  • Active T3 binds to thyroid hormone receptor beta (TRbeta) to upregulate key genes for mitochondrial beta-oxidation, such as CPT-1alpha, and promote lipid export.
  • When PEMT dysfunction impairs PC resilience and compromises VLDL export, the resulting triglyceride accumulation directly disrupts this thyroid hormone activation pathway, accelerating metabolic dysfunction.

Bottom line

  • The PEMT rs7946 CT variant impairs endogenous PC synthesis by 30%, reducing lipid export and creating a vulnerability to fat accumulation that directly compromises the hepatic DIO1/DIO3 pathways necessary for local thyroid hormone activation.

References

  1. Genetic variants in phosphatidylethanolamine N-methyltransferase and methylenetetrahydrofolate dehydrogenase influence biomarkers of choline metabolism when folate intake is restricted. — pmc.ncbi.nlm.nih.gov ↗
  2. PEMT rs7946 Polymorphism and Sex Modify the Effect of Adequate ... — pmc.ncbi.nlm.nih.gov ↗
  3. Common genetic polymorphisms affect the human ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  4. PEMT Val175Met (rs7946) - GeneOps — geneops.ai ↗
  5. Biochemical and Evolutionary Significance of Phospholipid Methylation* — jbc.org ↗
  6. Early induction of hepatic deiodinase type 1 inhibits hepatosteatosis during NAFLD progression — pmc.ncbi.nlm.nih.gov ↗
  7. Direct effects of thyroid hormones on hepatic lipid metabolism — pmc.ncbi.nlm.nih.gov ↗
  8. Metabolic Effects of the Intracellular Regulation of Thyroid Hormone — frontiersin.org ↗
  9. Thyroid Hormones and Thyromimetics: A New Approach to Nonalcoholic Steatohepatitis? — ncbi.nlm.nih.gov ↗
  10. Thyroid hormone-mediated autophagy and mitochondrial turnover in NAFLD — ncbi.nlm.nih.gov ↗
  11. The roles of autophagy and thyroid hormone in the pathogenesis and treatment of NAFLD — oaepublish.com ↗
  12. Phosphatidylcholine Homeostasis and Liver Failure* — jbc.org ↗
  13. Phosphatidylethanolamine N-methyltransferase: from Functions to Diseases — pmc.ncbi.nlm.nih.gov ↗
  14. Influence of Altered Thyroid Hormone Mechanisms in the ... — pdfs.semanticscholar.org ↗
  15. Cross-Talk Between Thyroid Disorders and Nonalcoholic Fatty ... — thieme-connect.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan obstructive sleep apnea lower testosterone in men?→Plausible5 sourcesDoes a non-elevated LH with low testosterone suggest secondary hypogonadism?→